Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is in line with its 5-year average of 92.20%, near the high end of its 5-year range (-153.30%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026. 25.00% above its 12-month average of 80.00%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
80.00%
GROSS MARGIN AVG 3Y
99.97%
GROSS MARGIN AVG 5Y
92.20%
GROSS MARGIN AVG 10Y
95.61%
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+25.00%
CURRENT VS 3Y AVG
+0.03%
CURRENT VS 5Y AVG
+8.46%
CURRENT VS 10Y AVG
+4.59%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+141.66%
vs the sector median at left
Market Cap
$30.85M
Gross Margin
83.79%
TTM Avg
85.97%
3Y Avg
84.60%
5Y Avg
84.69%
Market Cap
$30.36M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$29.66M
Gross Margin
-3398.93%
TTM Avg
-1699.46%
3Y Avg
-849.73%
5Y Avg
-566.49%
Market Cap
$31.77M
Gross Margin
16.44%
TTM Avg
14.13%
3Y Avg
15.03%
5Y Avg
13.67%
Market Cap
$29.54M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SCYNEXIS, Inc. (SCYX) | $30.66M | 100.00% | 80.00% | 99.97% | 92.20% |
| BeyondSpring Inc. (BYSI)vs › | $30.52M | 0.00% | 0.00% | 25.00% | 50.00% |
| MDxHealth S.A. (MDXH)vs › | $30.67M | 59.74% | 60.48% | 58.85% | 54.42% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $30.85M | 83.79% | 85.97% | 84.60% | 84.69% |
| CervoMed Inc. (CRVO)vs › | $30.74M | 0.00% | 0.00% | 0.00% | 0.00% |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.36M | 0.00% | 0.00% | 0.00% | 0.00% |
| GridAI Technologies Corp. (GRDX)vs › | $29.66M | -3398.93% | -1699.46% | -849.73% | -566.49% |
| Nortech Systems Incorporated (NSYS)vs › | $31.77M | 16.44% | 14.13% | 15.03% | 13.67% |
| Context Therapeutics Inc. (CNTX)vs › | $29.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| Quantum Cyber N.V. (QUCY)vs › | $29.48M | 79.97% | 68.44% | 57.05% | 51.79% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 100.00% |
| 2024-06-30 | 100.00% |
| 2024-03-31 | 100.00% |
| 2023-12-31 | -153.30% |
| 2023-09-30 | 78.48% |
| 2023-06-30 | 99.68% |
| 2023-03-31 | 87.88% |
| 2022-12-31 | 87.14% |
| 2022-09-30 | 87.86% |
| 2022-06-30 | 89.12% |
| 2022-03-31 | 85.59% |
| 2021-12-31 | 72.03% |
| 2021-09-30 | 71.90% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 100.00% |
| 2019-03-31 | 100.00% |
| 2018-12-31 | 100.00% |
| 2018-09-30 | 100.00% |
| 2018-06-30 | 100.00% |
| 2018-03-31 | 100.00% |
| 2017-12-31 | 100.00% |
| 2017-09-30 | 100.00% |
| 2017-06-30 | 100.00% |
| 2017-03-31 | 100.00% |
| 2016-12-31 | 100.00% |
| 2016-09-30 | 100.00% |
| 2016-06-30 | 100.00% |
| 2016-03-31 | 100.00% |
| 2015-12-31 | -4948.44% |
| 2015-09-30 | 100.00% |
| 2015-06-30 | 100.00% |
| 2015-03-31 | 2.00% |
| 2014-12-31 | 31.17% |
| 2014-09-30 | 16.44% |
| 2014-06-30 | 9.95% |
| 2014-03-31 | 15.83% |
| 2013-12-31 | -2.75% |
| 2013-09-30 | 4.25% |
| 2013-06-30 | -4.05% |
| 2013-03-31 | 13.49% |
